<?xml version="1.0" encoding="UTF-8"?>
<p>Patients were not eligible if they were scheduled to receive: (i) MEC or HEC from days 2 to 5 following cisplatin, (ii) moderately or highly emetogenic radiotherapy within 1 week before day 1 or between days 1 and 5, or (iii) a bone marrow or stem-cell transplant. Additional exclusion criteria included: receipt of medication with antiemetic effect &lt;24 h of day 1; vomiting, retching or mild nausea &lt;24 h before day 1; serious cardiovascular disease history or predisposition to cardiac conduction abnormalities except for incomplete right bundle branch block; or chronic use of select CYP3A4 inducers &lt;4 weeks or a substrate or inhibitor &lt;1 week before day 1.</p>
